RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention

By Christopher J. Donnelly, Ping-Wu Zhang, Jacqueline T. Pham, A. Haeusler, Nipun A. Mistry, Svetlana Vidensky, E. Daley, E. M. Poth, Benjamin Hoover, Daniel M. Fines and 10 more. Neuron, 2013

885 citations recorded by the source corpus.

SUMMARY A hexanucleotide GGGGCC repeat expansion in the noncoding region of the C9ORF72 gene is the most common genetic abnormality in familial and sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The function of the C9ORF72 protein is unknown, as is the mechanism by which the repeat expansion could cause disease. Induced pluripotent stem cell (iPSC)-differentiated neurons from C9ORF72 ALS patients revealed disease-specific (1) intranuclear GGGGCCexp RNA foci, (2) dysregulated gene expression, (3) sequestration of GGGGCCexp RNA binding protein ADARB2, and (4) susceptibility to excitotoxicity. These pathological and pathogenic characteristics were confirmed in ALS brain and were mitigated with antisense oligonucleotide (ASO) therapeutics to the C9ORF72 transcript or repeat expansion despite the presence of repeat-associated non-ATG translation (RAN) products. These data indicate a toxic RNA gain-of-function mechanism as a cause of C9ORF72 ALS and provide candidate antisense therapeutics and candidate human pharmacodynamic markers for therapy.

Subfields: Cellular and Molecular Neuroscience, Genetics, Neurology

View Paper: https://www.semanticscholar.org/paper/3c467ef9d1628d993c9c807629b1484aa4180bb3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. K. Carr
  2. W. Pagani
  3. G. Orozco
  4. K. Díaz
  5. S. Zarei
  6. P. Altamirano
  7. Orleiquis Guerra
  8. Á. Chinea

Citations in the corpus